skip to content

Office for Translational Research

 

In most cases, COVID funding calls have now been incorporated into funders’ standard channels. Please contact the Office for Translational Research for guidance on suitability of calls for your individual research requirements.

COVID-related projects may be supported by the following major funders:

 

Other Funders

CEPI (Coalition for Epidemic Preparedness Innovations)

CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates.

Deadline Date:  Rolling submission

  • External call
  • For further information contact: cfp@cepi.net
  • Funding level: Not specified
 
Horizon 2020 Framework Programme:  European Research Area Corona Platform

The European Research Area corona platform is a one-stop shop providing comprehensive information about funding opportunities in relation to Coronavirus at European Union and national level.  (please visit the link)

Deadline Date:  Rolling submission

  • External call
  • Funding level: Not specified
 
Mozilla Open Source Support Program: COVID-19 Solutions Fund

Funding for reasonably mature open source technology projects which are responding to the COVID-19 pandemic in some way such as hardware, software and software which provides solutions for secondary effects of COVID-19.

Deadline Date:  Rolling submission

  • External call
  • Funding level:  Up to $50K
 
National Institutes of Health (US) 
Central source of information on NIH COVID-related research funding calls (please refer to the above link) 
 
 
UK Research and Innovation opportunity to get funding for ideas that address COVID-19
 

December 2020

NIHR and UKRI  Research into the longer term effects of COVID-19 in non-hospitalised individuals

The NIHR and UK Research and Innovation (UKRI) has launched a joint research call to fund ambitious and comprehensive research into the longer term physical and mental effects of COVID-19.  
The NIHR and UKRI have jointly funded major studies to characterise acute and longer term disease in hospitalised patients, for example the UK-wide ISARIC-4C  and Post hospitalisation COVID-19 (PHOSP-COVID) study.

Projects are expected to start early in 2021 and may be funded for up to 3 years in the first instance.

Deadline Date:  9th December 2020.

  • External
  • Funding level:  Up to £20m will be available for this call
 

January 2021

 
Novo Nordisk Foundation Research in long-term health consequences of COVID-19 illness

The purpose of the programme will be to support collaborative projects that investigate the nature, incidence, distribution of long-term symptoms, and their underlying pathogenesis in COVID-19 patients as well as to develop and test treatments for long-term COVID-19 illness. The current thematic call is aimed to fund projects that:

  1. Investigate the nature, incidence, distribution and duration of long-term symptoms, and their underlying pathogenesis in COVID-19 patients.
  2. Development and test treatments for long-term COVID-19 illness.

Deadline Date:  12th January 2021 by 2pm(CET).

  • External
  • Funding level:  Max. DKK 40 million
 
MSK TRC Accelerating New Treatments Versus Arthritis

Versus Arthritis are funding research around the UK Musculoskeletal Translational Research Collaboration, a partnership between NIHR and Versus Arthritis.

Applications should be focused on an unmet arthritis need, within or across the collaboration’s themes. Studies that tackle related COVID-19 questions are also encouraged.

Deadline Date:  18th January 2021 by 16:00hrs.

  • External
  • Funding level:  Max. £300 K